Biogennix’s DirectCell Advanced Bone Grafting System Used in 500th Case

IRVINE, Calif. – Might 17, 2022 / OrthoSpineNews / – Irvine-based Biogennix, a market chief in superior bone regeneration expertise, introduced immediately that its DirectCell Superior Bone Grafting System has already been utilized in over 500 circumstances.

Biogennix’s group of bone regeneration consultants particularly designed this method to offer surgeons and hospitals with a complete bone graft answer in a single product. The DirectCell System features a bone graft product with superior bone regeneration properties together with novel instrumentation engineered to reap excessive concentrations of affected person stem cells.

The cell-stimulating graft throughout the system is the superior artificial bone graft, Agilon, which is accessible in a Moldable and Strip kind. Agilon merchandise are primarily based on Biogennix’s distinctive TrelCor expertise that accommodates a nanocrystalline hydroxycarbanoapatite graft floor which actively participates in bone regeneration. The DirectCell System additionally supplies surgeons two strategies of amassing bone marrow derived stem cells, both by means of the harvesting of stem cell aspirate (SCA) with considerably increased stem cell counts [compared to standard bone marrow aspirate (BMA)], or marrow-rich autograft dowels.

Collectively, the applied sciences throughout the DirectCell System enable surgeons to leverage each superior materials properties and the ability of a affected person’s personal stem cells.

“The DirectCell System supplies surgeons the means to reap tissue with excessive stem cell counts and mix it with a graft materials that’s actively concerned within the mobile bone formation response­­,” stated Mark Borden, PhD, Biogennix’s CTO.  “This leads to an optimum organic graft that instantly begins the bone regeneration course of.”

The DirectCell System is rising in a number of market segments, at the moment seeing strongest progress with backbone surgeons and foot and ankle surgeons.

Dr. Jeffrey Wang, Chief of Orthopaedic Backbone Service at USC and Co-Director of the USC Backbone Middle, has been utilizing the DirectCell System in his backbone fusion circumstances. “Whenever you mix reside cells with a sophisticated floor, you’re optimizing the therapeutic response,” stated Dr. Wang. “Surgeons and hospitals alike want progressive options with sturdy scientific backing, which incorporate new organic applied sciences.”

Dr. Brett Sachs, reconstructive foot and ankle surgeon and Program Director for the Highlands-Presbyterian/St. Luke’s Residency Program, is utilizing the DirectCell System for main reconstructive circumstances. “I like that I can harvest marrow wealthy autograft dowels from the calcaneus or tibia, and mix it with a sophisticated graft that handles and mixes extraordinarily properly,” stated Dr. Sachs. “Particularly for difficult circumstances, I really feel like I’m giving my sufferers the very best likelihood for a profitable fusion.”

The DirectCell System is Biogennix’s newest innovation in its decade-plus historical past of delivering superior bone graft applied sciences to the market.

“As an organization our power has all the time been our focus and deep experience in superior bone regeneration applied sciences,” stated Biogennix CEO Chris MacDuff. “I attribute the swift success of the DirectCell System primarily to the strong science supporting its advantages.”

MacDuff additionally described the necessity for options that aren’t solely clinically efficient, however protected for sufferers.

“Whenever you use the affected person’s personal cells, you fully eradicate the chance of illness transmission that has lately been seen with a cadaver-based stem cell merchandise,” stated MacDuff. “The DirectCell System not solely permits the harvest of considerably increased cell counts, however it’s a safer and considerably more cost effective various.”

The DirectCell System is accessible with Biogennix’s bioactive bone grafts, Agilon Moldable or Agilon Strip.

###

Biogennix® is a market chief in superior bone regeneration applied sciences. Biogennix is headquartered in Irvine, CA the place they develop, manufacture, and distribute proprietary applied sciences utilized in bone fusion procedures. Biogennix group members are consultants in bone graft science who’re targeted on creating options that maintain distributors and surgeons on the forefront of bone regeneration. Study extra at biogennix.com.